MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma von Chen, Lucia Y., Thibaud, Santiago, Bodnar, Saoirse, Chari, Ajai, Richter, Joshua, Cho, Hearn Jay, Sanchez, Larysa J., Rodriguez, Cesar, Rossi, Adriana C., Richard, Shambavi, Parekh, Samir, Jagannath, Sundar

Volltext

Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival von Avigan, Zachary M., Bodnar, Saoirse, Pan, Darren, Catlett, Jerrel, Richter, Joshua, Sanchez, Larysa J., Rodriguez, Cesar, Rossi, Adriana C., Richard, Shambavi, Jagannath, Sundar, Cho, Hearn Jay, Parekh, Samir, Thibaud, Santiago

Volltext

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies von Lancman, Guido, Parsa, Kian, Kotlarz, Krzysztof, Avery, Lisa, Lurie, Alaina, Lieberman-Cribbin, Alex, Cho, Hearn Jay, Parekh, Samir S, Richard, Shambavi, Richter, Joshua, Rodriguez, Cesar, Rossi, Adriana, Sanchez, Larysa J, Thibaud, Santiago, Jagannath, Sundar, Chari, Ajai

Volltext

Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution's experience over 14 years von Duma, Narjust, Sanchez, Larysa J, Castro, Yulanka S, Jennis, Andrew A, McCain, Donald A, Gutierrez, Martin E, Bamboat, Zubin M

Volltext

Durable MRD and Imaging-Negative Remission ≥ 5 Years Post-Therapy Predicts Long-Term Progression-Free Survival in Multiple Myeloma Patients - a Single-Center Observational Study von Chen, Lucia Y, Thibaud, Santiago, Chari, Ajai, Richter, Joshua, Cho, Hearn Jay, Sanchez, Larysa J, Rodriguez, Cesar, Rossi, Adriana C, Richard, Shambavi, Parekh, Samir, Jagannath, Sundar

Volltext

Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy von Pan, Darren Denjay, Mouhieddine, Tarek H., Fu, Weijia, Moshier, Erin, Parekh, Samir, Jagannath, Sundar, Rossi, Adriana C, Cho, Hearn Jay, Richter, Joshua, Sanchez, Larysa J, Thibaud, Santiago, Rodriguez, Cesar, Richard, Shambavi

Volltext

Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of Multiple Myeloma Patients von Thibaud, Santiago, Genthe, William, Bodnar, Saoirse, Lagana, Alessandro, Houldsworth, Jane, Chari, Ajai, Rossi, Adriana C, Rodriguez, Cesar, Sanchez, Larysa J, Richard, Shambavi, Richter, Joshua, Onel, Kenan, Jagannath, Sundar, Brander, Tehilla, Parekh, Samir

Volltext

Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease von Pan, Darren, Mouhieddine, Tarek H., Fu, Weijia, Moshier, Erin, Parekh, Samir, Jagannath, Sundar, Rossi, Adriana C, Richter, Joshua, Rodriguez, Cesar, Sanchez, Larysa J, Thibaud, Santiago, Cho, Hearn Jay, Richard, Shambavi

Volltext

Inflammatory Marker Levels, Age, Race and Prior Treatment Burden Independently Predict Delayed Hematologic Recovery after BCMA-Directed CART Therapy in Multiple Myeloma von Thibaud, Santiago, Catlett, Jerrel, Bodnar, Saoirse, Mia, MD Babu, Chari, Ajai, Richter, Joshua, Cho, Hearn Jay, Sanchez, Larysa J, Rodriguez, Cesar, Rossi, Adriana C, Jagannath, Sundar, Richard, Shambavi, Parekh, Samir

Volltext

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy von Van Oekelen, Oliver, Nath, Karthik, Mouhieddine, Tarek H., Farzana, Tasmin, Aleman, Adolfo, Melnekoff, David T., Ghodke-Puranik, Yogita, Shah, Gunjan L., Lesokhin, Alexander, Giralt, Sergio, Thibaud, Santiago, Rossi, Adriana, Rodriguez, Cesar, Sanchez, Larysa, Richter, Joshua, Richard, Shambavi, Cho, Hearn J., Chari, Ajai, Usmani, Saad Z., Jagannath, Sundar, Shah, Urvi A., Mailankody, Sham, Parekh, Samir

Volltext

Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies von Lancman, Guido, Parsa, Kian, Rodriguez, Cesar, Richter, Joshua, Cho, Hearn J., Parekh, Samir, Richard, Shambavi, Rossi, Adriana, Sanchez, Larysa, Thibaud, Santiago, Jagannath, Sundar, Chari, Ajai

Volltext

Bispecific Antibodies in Multiple Myeloma: Present and Future von Lancman, Guido, Sastow, Dahniel L, Cho, Hearn J, Jagannath, Sundar, Madduri, Deepu, Parekh, Samir S, Richard, Shambavi, Richter, Joshua, Sanchez, Larysa, Chari, Ajai

Volltext

Early detection of CRS after CAR-T therapy using wearable monitoring devices: Preliminary results in relapsed/refractory multiple myeloma (RRMM) von Rajeeve, Sridevi, Wilkes, Matt, Zahradka, Nicole, Serebyrakova, Kseniya, Kappes, Katerina, Jackson, Hayley, Buchenholz, Nicole, Agte, Sarita, Thibaud, Santiago, Sanchez, Larysa Jessica, Richard, Shambavi, Richter, Joshua Ryan, Rodriguez, Cesar, Cho, Hearn J., Chari, Ajai, Jagannath, Sundar, Rossi, Adriana, Parekh, Samir S.

Volltext

Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax von Lagana, Alessandro, Thibaud, Santiago, Melnekoff, David T., Restrepo, Paula, Leshchenko, Violetta, McCafferty, Jonathan, Newman, Scott, Kern, Abbi, Corrigan, David, Hantash, Feras, Rossi, Adriana, Rodriguez, Cesar, Sanchez, Larysa, Richard, Shambavi, Chari, Ajai, Cho, Hearn J., Jagannath, Sundar, Richter, Joshua, Parekh, Samir

Volltext

Immune Recovery Post BCMA CAR-T: Implications for Infection Prophylaxis and Vaccinations von Richard, Shambavi, Lancman, Guido, Thibaud, Santiago, Chari, Ajai, Parekh, Samir, Rossi, Adriana, Cho, Hearn J., Sanchez, Larysa, Richter, Joshua, Rodriguez, Cesar, Aronson, Elizabeth, Louw, Karen, Purcell, Kiah, Verina, Daniel, Escalon, Juliet, Jagannath, Sundar

Volltext

Extramedullary Relapse Post CAR-T von Richard, Shambavi, Lancman, Guido, Rossi, Adriana, Chari, Ajai, Parekh, Samir, Sanchez, Larysa, Rodriguez, Cesar, Cho, Hearn J., Richter, Joshua, Thibaud, Santiago, Purcell, Kiah, Aronson, Elizabeth, Verina, Daniel, Escalon, Juliet, Louw, Karen, Jagannath, Sundar

Volltext

Salvage with Sequential T Cell Redirection for Myeloma Patients Who Have Previously Progressed on T Cell Directed Therapy Is Associated with Significant Cellular Activation of the... von Aleman, Adolfo, Kogan Zajdman, Ariel, Ghodke-Puranik, Yogita, Upadhyaya, Bhaskar, Mouhieddine, Tarek H., Van Oekelen, Oliver, Sanchez, Larysa, Richard, Shambavi, Rossi, Adriana, Richter, Joshua, Cho, Hearn J., Rodriguez, Cesar, Chari, Ajai, Jagannath, Sundar, Parekh, Samir

Volltext

Timing and Nature of Infections in Multiple Myeloma Patients Treated with Anti-BCMA CAR-T Cells von Lancman, Guido, Shyu, Margaret, Metzger, Megan, Parsa, Kian, Cho, Hearn J., Parekh, Samir, Richter, Joshua, Rodriguez, Cesar, Rossi, Adriana, Sanchez, Larysa, Thibaud, Santiago, Jagannath, Sundar, Chari, Ajai, Richard, Shambavi

Volltext

P-077 Prophylactic Tocilizumab to Mitigate Cytokine Release Syndrome in Patients Receiving Talquetamab for Relapsed/Refractory Multiple Myeloma: Results From the Phase 1/2 MonumenT... von Schinke, Carolina, Vij, Ravi, Jagannath, Sundar, Sanchez, Larysa, Pianko, Matthew, Jakubowiak, Andrzej, Masterson, Tara J, Campagna, Michela, Zhang, Guoqiang, Gray, Kathleen, Renaud, Thomas, Lau, Bonnie W, Morgan, Gareth

Volltext

Clinical Outcomes of Subsequent Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 MonumenTAL-1 Study von Sanchez, Larysa, Schinke, Carolina, Krishnan, Amrita, Berdeja, Jésus G, van de Donk, Niels WCJ, Mateos, María Victoria, Chari, Ajai, Parekh, Samir, Mouhieddine, Tarek H., Jagannath, Sundar, Bahlis, Nizar J, Touzeau, Cyrille, Oriol, Albert, San-Miguel, Jesus, Rodriguez Otero, Paula, Minnema, Monique C, Campagna, Michela, Masterson, Tara J, Hilder, Brandi W, Tolbert, Jaszianne, Renaud, Thomas, Gray, Kathleen, Smit, Damiette, Heuck, Christoph, Rasche, Leo

Volltext